Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

ADGHW is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme ‘Towards Longevity: Redefining Health and Well-being.’ It places a strong ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Shares of another HIV drugmaker, GSK plc GSK, were also down 2.08% on the news. However, the direct impact of this reduction under the Trump administration on these drugmakers is likely to be minimal.

When I’ve made mistakes on people, it’s usually for cultural reasons,” Walmsley told Norges Bank Investment Management CEO ...

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

Additionally, the company has developed next-generation drugs in respiratory and HIV areas that should help mitigate both branded and generic competition. We expect GSK to be a major competitor in ...

What it means: A reduction to the CDC's HIV budget has implications for drugmakers focused on combating this disease. Aside from Gilead, American depositary shares of GSK fell 2.18% in early trading.